Work

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Year: 2018

Type: article

Study design: Case Report

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.04.007

Authors: Lei Deng, Lesli A. Kiedrowski, Elizabeth Ravera, Haiying Cheng, Balazs Halmos

Institutions: Albert Einstein College of Medicine, Jacobi Medical Center, Guardant (United States), Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2888796573

FWCI: 5.239

Cites: 10

Cited by: 56

Related to: 10